Xenetic Biosciences, Inc. - XBIO
About Gravity Analytica
Recent News
- 08.13.2025 - 8-K - Current report
- 08.13.2025 - Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results
- 08.12.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 07.30.2025 - Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma
- 07.23.2025 - Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
- 07.08.2025 - Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
- 05.14.2025 - 8-K - Current report
- 05.14.2025 - Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
- 05.13.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05.13.2025 - 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]